NCT02221453View on ClinicalTrials.gov

Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Diabetic Macular Edema
Interventions
DRUG

Triamcinolone Acetonide

Trial Locations (1)

M5C2T2

St. Michael's Hospital Eye Clinic, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT02221453 - Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide | Biotech Hunter | Biotech Hunter